drugset / Trial / NCT02872818

Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia

NCT02872818

Phase 4 Completed 40 enrolled Kayseri Education and Research Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to determine apoptotic signaling pathways such as Survivin, Bcl-2, Bax, c-Myc and caspase-9 expression levels in rats model with iatrogenic endometrial hyperplasia after metformin and medroxyprogesterone acetate administration.

Timeline

Start
2014-10
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 50 mg/kg
Comparator medroxyprogesterone acetate Other / unclassified 1 mg/kg
Comparator Estradiol Other / unclassified 4 mg/kg

Indications